Imexpharm has been recognized among Vietnam’s Top 50 Best Performing Companies in 2017.
This prestigious award, organized by Nhịp Cầu Đầu Tư Magazine in collaboration with Tien Viet Securities Company (TVS), highlights Imexpharm’s effective business results, stable long-term investment strategy, and strong corporate governance under its leadership. The event has attracted considerable attention from economic experts and investors, both domestically and internationally.
The esteemed award is based on surveys and rankings of listed companies, utilizing scientific measurement methods according to international standards, with the guidance of financial analysts from Tien Viet Securities Company, Vietnam Investment Group (VIG) Fund Management Company, and Vietnam Capital Partners (VCP) Fund Management Company. The evaluation board includes experts from Harvard Business School (USA) and other reputable international business organizations.